Skip to main content

Table 5 Patient data at six-month follow-up by HbA1c and SBP target group

From: Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry

HbA1c

HbA1c ≤ 6.5%(n = 2,647)

HbA1c > 6.5% to ≤ 7.0%(n = 2,790)

HbA1c >7.0% to ≤ 7.5%(n = 1,149)

P-values for the comparison of 3 groups

GP contacts (number)

5.5 ± 4.8

4.7 ± 3.9

5.3 ± 4.4

<0.001

Specialist contacts (number)

2.3 ± 1.9

2.3 ± 2.7

2.3 ± 2.1

<0.05

Fasting glucose (mmol/l)

7.0 ± 2.0

7.4 ± 1.9

8.4 ± 2.8

<0.0001

Postprandial glucose (mmol/l)

8.4 ± 2.5

8.9 ± 2.7

9.8 ± 3.1

<0.0001

HbA1c (%)

6.8 ± 0.9

7.2 ± 0.9

7.7 ± 1.2

<0.0001

∆HbA1c from baseline (%)

-0.4 ± 1.2

-0.7 ± 1.2

-0.9 ± 1.5

<0.0001

SBP (mmHg)

135.3 ± 14.1

135.8 ± 13.9

136.7 ± 14.1

<0.01

∆SBP from baseline (mmHg)

-4.2 ± 16.7

-5.1 ± 15.6

-4.7 ± 15.5

0.06

DBP (mmHg)

80.8 ± 8.8

80.3 ± 8.5

80.4 ± 8.5

0.27

SBP

SBP ≤ 130 mmHg (n = 2,602)

SBP > 130 to ≤ 135 mmHg (n = 2,225)

SBP > 135 to ≤ 140 mmHg (n = 1,729)

P-values for the comparison of 3 groups

GP contacts (number)

5.5 ± 4.8

4.7 ± 3.7

5.2 ± 4.5

<0.0001

Specialist contacts (number)

2.3 ± 2.0

2.3 ± 2.4

2.3 ± 2.6

0.34

Fasting glucose (mmol/l)

7.2 ± 2.2

7.4 ± 2.0

7.7 ± 2.3

<0.0001

Postprandial glucose (mmol/l)

8.8 ± 2.7

8.9 ± 2.3

8.9 ± 3.3

<0.01

HbA1c (%)

7.0 ± 1.1

7.2 ± 1.0

7.2 ± 1.1

<0.0001

∆HbA1c from baseline (%)

-0.5 ± 1.2

-0.7 ± 1.2

-0.7 ± 1.3

<0.0001

SBP (mmHg)

133.4 ± 13.4

135.7 ± 13.3

139.1 ± 14.9

<0.0001

∆SBP from baseline (mmHg)

-3.0 ± 16.5

-5.2 ± 15.2

-6.4 ± 16.3

<0.0001

DBP (mmHg)

79.9 ± 8.3

80.5 ± 8.2

81.4 ± 9.4

<0.0001

  1. Legend: HbA1c, glycated hemoglobin; SBP, systolic blood pressure; GP, general practitioner; DBP, diastolic blood pressure; data are provided as mean ± standard deviation.